Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

Filed under: News |

LONDON (Reuters) – Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.

Source:: http://feeds.reuters.com/~r/reuters/businessNews/~3/vnqGIPlFzrY/shire-sells-cancer-drugs-to-servier-for-2-4-billion-as-takeda-circles-idUSKBN1HN0P8

      

List your business in the premium web directory for free This website is listed under Human Resources Directory